Temporal differences between the involvement of angiotensin II and endothelin in the cardiovascular responses to endotoxaemia in conscious rats

British Journal of Pharmacology

Volumn 119, Issue 8, 1996, Pages 1619-1627

  Gardiner, S M ^a   Kemp, P A ^a   March, J E ^a   Bennett, T ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Angiotensin II; Captopril; d(CH2)5 O Me Tyr AVP; Endothelin; Lipopolysaccharide; Losartan; SB 209670; Vasopressin

Indexed keywords

3 (2 CARBOXYMETHOXY 4 METHOXYPHENYL) 1 (3,4 METHYLENEDIOXYPHENYL) 5 PROPOXY 2 INDANCARBOXYLIC ACID; ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; CAPTOPRIL; ENDOTHELIN; ENDOTHELIN RECEPTOR ANTAGONIST; LIPOPOLYSACCHARIDE; LOSARTAN; VASOPRESSIN V1 RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; BLOOD FLOW; CARDIOVASCULAR RESPONSE; CONTROLLED STUDY; DOPPLER FLOWMETRY; ENDOTOXEMIA; HEMODYNAMIC MONITORING; HYPOTENSION; INTRAVASCULAR CATHETER; KIDNEY BLOOD FLOW; LIMB BLOOD FLOW; MALE; MEAN ARTERIAL PRESSURE; MESENTERY BLOOD VESSEL; NONHUMAN; PRIORITY JOURNAL; RAT; VASODILATATION;

EID: 0030475844     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1996.tb16081.x     Document Type: Article

References (35)

1. BATIN, P., GARDINER, S.M., COMPTON, A.M. & BENNETT, T. (1991). Differential regional haemodynamic effects of the non-peptide angiotensin II antagonist, DuP 753, in water-replete and water-deprived Brattleboro rats. Life Sci., 48, 733-739.
2. BONE, R.C. (1991). The pathogenesis of sepsis. Ann. Int. Med., 115, 457-469.
3. 9-BK-induced rat paw oedema by systemic treatment with bacterial endotoxin. Br. J. Pharmacol., 117, 793-798.
4. DOUGLAS, S.A., EDWARDS, R.M., ELLIOTT, J.D. & OHLSTEIN, E.H. (1995a). In vivo pharmacological characterization of the non-peptide endothelin receptor antagonist SB 209670. Br. J. Pharmacol., 114, 405-413.
5. DOUGLAS, S.A., GELLAI, M., EZEKEIL, M., FEUERSTEIN, G.Z., ELLIOTT, J.D. & OHLSTEIN, E.H. (1995b). Antihypertensive actions of the novel nonpeptide endothelin receptor antagonist SB 209670. Hypertension, 25, 818-822.
6. FASCIOLO, J.C., VARGAS, L., LAMA, M.C. & NOLLY, H. (1990). Bradykinin-induced vasoconstriction of rat mesenteric arteries precontracted with noradrenaline. Br. J. Pharmacol., 101, 344-348.
7. GARDINER, S.M. & BENNETT, T. (1992). Involvement of nitric oxide in the regional haemodynamic effects of perindoprilat and captopril in hypovolaemic Brattleboro rats. Br. J. Pharmacol., 107, 1181-1191.
8. GARDINER, S.M., BENNETT, T. & COMPTON, A.M. (1988). Regional haemodynamic effects of neuropeptide Y, vasopressin and angiotensin II in conscious, unrestrained, Long Evans and Brattleboro rats. J. Autonom. Nerv. Syst., 24, 15-27.
9. GARDINER, S.M., COMPTON, A.M. & BENNETT, T. (1989). Regional hemodynamic changes following hypovolaemia in conscious rats. Am. J. Physiol., 256, R1076-R1083.
10. GARDINER, S.M., KEMP, P.A., MARCH, J.E. & BENNETT, T. (1995a). Enhancement of the hypotensive and vasodilator effects of endotoxaemia in conscious rats by the endothelin antagonist, SB 209670. Br. J. Pharmacol., 116, 1718-1719.
11. GARDINER, S.M., KEMP, P.A., MARCH, J.E. & BENNETT, T. (1995b). Cardiac and regional haemodynamics, inducible nitric oxide synthase (NOS) activity, and the effects of NOS inhibitors in conscious, endotoxaemic rats. Br. J. Pharmacol., 116, 2005-2016.
12. GARDINER, S.M., KEMP, P.A., MARCH, J.E. & BENNETT, T. (1996a). Effects of dexamethasone and SB 209670 on the regional haemodynamic responses to lipopolysaccharide in conscious rats. Br. J. Pharmacol., 118, 141-149.
13. GARDINER, S.M., KEMP, P.A., MARCH, J.E. & BENNETT, T. (1996b). Influence of aminoguanidine and the endothelin antagonist, SB 209670, on the regional haemodynamic effects of endotoxaemia in conscious rats. Br. J. Pharmacol., 118, 1822-1828.
14. GARDINER, S.M., MARCH, J.E., KEMP, P.A., MULLINS, J.J. & BENNETT, T. (1995c). Haemodynamic effects of losartan and the endothelin antagonist, SB 209670, in conscious, transgenic ((mRen-2)27), hypertensive rats. Br. J. Pharmacol., 116, 2237-2244.
15. GUC, M.O., FURMAN, B.L. & PARRATT, J.R. (1990). Endotoxin-induced impairment of vasopressor and vasodepressor responses in the pithed rat. Br. J. Pharmacol., 101, 913-919.
16. HAUSER, G.J., DAYAO, E.K. & ZUKOWSKA-GROJEC, Z. (1995). Effect of neuropeptide Y on endotoxin-induced suppression of the response to various agonists in conscious rats. Life Sci., 57, 235-244.
17. KASTING, N.W., MAZUREK, M.F. & MARTIN, J.B. (1985). Endotoxin increases vasopressin release independently of known physiological stimuli. Am. J. Physiol., 248, E420-E424.
18. KATORI, M., MAJIMA, M., ODOI-ADOME, R., SUNAHARA, N. & UCHIDA, Y. (1989). Evidence for the involvement of a plasma kallikrein-kinin system in the immediate hypotension produced by endotoxin in anaesthetized rats. Br. J. Pharmacol., 98, 1383-1391.
19. LINZ, W., WIEMER, G., GOHLKE, P., UNGER, T. & SCHÖLKENS, B.A. (1995). Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors. Pharmacol. Rev., 47, 25-49.
20. MOMBOULI, J-V. & VANHOUTTE, P.M. (1995). Kinins and endothelial control of vascular smooth muscle. Annu. Rev. Pharmacol. Toxicol., 35, 679-705.
21. MOMOSE, N., FUKUO, K., MORIMOTO, S. & OGIHARA, T. (1993). Captopril inhibits endothelin-1 secretion from endothelial cells through bradykinin. Hypertension, 21, 921-924.
22. MULLER, A.F., GARDINER, S.M., COMPTON, A.M. & BENNETT, T. (1990). Regional haemodynamic effects of captopril, enlaprilat and lisinopril in conscious water-replete and water-deprived Brattleboro rats. Clin. Sci., 79, 393-401.
23. OHLSTEIN, E.H., NAMBI, P., DOUGLAS, S.A., EDWARDS, R.M., GELLAI, M., LAGO, A., LEBER, J.D., COUSINS, R.D., GAO, A., FRAZEE, J.S., PEISHOFF, C.E., BEAN, J.W., EGGLESTON, D.S., ELSHOURBAGY, N.A., KUMAR, C., LEE, J.A., YUE, T-L., LOUDEN, C., BROOKS, D.P., WEINSTOCK, J., FEUERSTEIN, G., POSTE, G., RUFFOLO, R.R., GLEASON, J.G. & ELLIOTT, J.D. (1994). SB 209670, a rationally designed potent nonpeptide endothelin receptor antagonist. Proc. Natl. Acad. Sci. U.S.A., 91, 8052-8056.
24. PARRATT, J.R. (1973). Myocardial and circulatory effects of E coli endotoxin: modification of responses to catecholamines. Br. J. Pharmacol., 47, 12-25.
25. PAYA, D. & STOCLET, J.C. (1995). Involvement of bradykinin and nitric oxide in the early hemodynamic effects of lipopolysaccharide in rats. Shock, 3, 376-379.
26. REGOLI, D. & BARABÉ, J. (1980). Pharmacology of bradykinin and related kinins. Pharmacol. Rev., 32, 1-46.
27. RUETTEN, H., THIEMERMANN, C. & VANE, J.R. (1996). Effects of the endothelin receptor antagonist, SB 209670, on circulatory failure and organ injury in endotoxic shock in the anaesthetized rat. Br. J. Pharmacol., 118, 198-204.
28. SCHALLER, M.D., WAEBER, B., NUSSBERGER, J. & BRUNNER, H.R. (1985). Angiotensin II, vasopressin, and sympathetic activity in conscious rats with endotoxaemia. Am. J. Physiol., 249, H1086-H1092.
29. SUGIURA, M., INAGAMI, T. & KON, V. (1989). Endotoxin stimulates endothelin-release in vivo and in vitro as determined by radioimmunoassay. Biochem. Biophys. Res. Commun., 161, 1220-1227,
30. SZABO, C., MITCHELL, J.A., THIEMERMANN, C. & VANE, J.R. (1993). Nitric oxide-mediated hyporeactivity to noradrenaline precedes the induction of nitric oxide synthase in endotoxin shock. Br. J. Pharmacol., 108, 786-792.
31. VEMULAPALLI, S., CHIU, P.J.S., RIVELLI, M., FOSTER, C.J. & SYBERTZ, E.J. (1991). Modulation of circulating endothelin levels in hypertension and endotoxaemia in rats. J. Cardiovasc. Pharmacol., 18, 895-903.
32. WALLER, J., GARDINER, S.M. & BENNETT, T. (1994). Regional haemodynamic responses to acetylcholine, methoxamine, salbutamol and bradykinin during lipopolysaccharide infusion in conscious rats. Br. J. Pharmacol., 112, 1057-1064.
33. WELLINGS, R.P., CORDER, R. & VANE, J.R. (1995). Lack of effect of ET antibody or SB 209670 on endotoxin-induced renal failure. J. Cardiovasc. Pharmacol., 26, S476-S478.
34. YOSHIDA, K., YASUJIMA, M., KOHZUKI, M., KANAZAWA, M., YOSHINAGA, K. & ABE, K. (1992). Endothelin-1 augments pressor response to angiotensin II infusion in rats. Hypertension, 20, 292-297.
35. YOSHIDA, K., YASUJIMA, M., KOHZUKI, M., TSUNODA, K., KUDO, K., KANAZAWA, M., YABE, T., ABE, K. & YOSHINAGA, K. (1991). Chronic synergistic effect of endothelin-1 and angiotenin II on blood pressure in conscious rats. J. Cardiovasc. Pharmacol., 17, S514-S516.